Advertisement

T-Cell Promiscuity in Autoimmune Diabetes

  1. Li Li,
  2. Bo Wang,
  3. Jeffrey A. Frelinger and
  4. Roland Tisch
  1. From the Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  1. Corresponding author: Roland Tisch, rmtisch{at}med.unc.edu

Abstract

OBJECTIVE—It is well established that the primary mediators of β-cell destruction in type 1 diabetes are T-cells. Nevertheless, the molecular basis for recognition of β-cell–specific epitopes by pathogenic T-cells remains ill defined; we seek to further explore this issue.

RESEARCH DESIGN AND METHODS—To determine the properties of β-cell–specific T-cell receptors (TCRs), we characterized the fine specificity, functional and relative binding avidity/affinity, and diabetogenicity of a panel of GAD65-specific CD4+ T-cell clones established from unimmunized 4- and 14-week-old NOD female mice.

RESULTS—The majority of GAD65-specific CD4+ T-cells isolated from 4- and 14-week-old NOD female mice were specific for peptides spanning amino acids 217–236 (p217) and 290–309 (p290). Surprisingly, 31% of the T-cell clones prepared from 14-week-old but not younger NOD mice were stimulated with both p217 and p290. These promiscuous T-cell clones recognized the two epitopes when naturally processed and presented, and this dual specificity was mediated by a single TCR. Furthermore, promiscuous T-cell clones demonstrated increased functional avidity and relative TCR binding affinity, which correlated with enhanced islet infiltration on adoptive transfer compared with that of monospecific T-cell clones.

CONCLUSIONS—These results indicate that promiscuous recognition contributes to the development of GAD65-specific CD4+ T-cell clones in NOD mice. Furthermore, these findings suggest that T-cell promiscuity reflects a novel form of T-cell avidity maturation.

Footnotes

  • Published ahead of print at http://diabetes.diabetesjournals.org on 20 May 2008.

  • Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted April 29, 2008.
    • Received March 18, 2008.
| Table of Contents

This Article

  1. Diabetes August 2008 vol. 57 no. 8 2099-2106
  1. » Abstract
  2. All Versions of this Article:
    1. db08-0383v1
    2. 57/8/2099 most recent

Social Bookmarking

Advertisement